Literature DB >> 9337876

Evidence that a kinase distinct from protein kinase C and phosphatidylinositol 3-kinase mediates ligation-dependent serine/threonine phosphorylation of the T-lymphocyte co-stimulatory molecule CD28.

R V Parry1, D Olive, J Westwick, D M Sansom, S G Ward.   

Abstract

The CD28 cytoplasmic tail contains several potential phosphorylation sites for the serine/threonine kinase protein kinase C (PKC) and/or proline-directed serine/threonine kinases, such as extracellular signal-regulated kinases. We demonstrate that ligation of CD28 by B7.1 results in strong serine/threonine phosphorylation of CD28. It is unlikely that ligation-stimulated phosphorylation of CD28 is mediated via activation of PKC, since it was not prevented by pre-treatment of Jurkat cells with inhibitors of PKC, and it was not mimicked by treatment with PKC activators such as PMA. Nevertheless, despite for lack of detectable effects of PMA treatment on CD28 phosphorylation, PMA did partially inhibit the association of CD28 with the putative signalling molecule phosphatidylinositol 3-kinase (PI 3-kinase) and the subsequent accumulation of PtdIns(3,4,5)P3. PI 3-kinase exhibits dual specificity as both a lipid kinase and a protein serine kinase, and site-specific mutagenesis of the Tyr173 residue in the CD28 cytoplasmic tail, which abolishes CD28 coupling to PI 3-kinase [Pages, Ragueneau, Rottapel, Truneh, Nunes, Imbert and Olive (1994) Nature (London) 369, 327-329], also prevents ligation-stimulated phosphorylation of CD28. However, the two PI 3-kinase inhibitors wortmannin and LY294002 had no effect on phosphorylation of CD28 after ligation by B7.1. This study therefore demonstrates that (1) a CD28-activated serine/threonine kinase distinct from both PKC and PI 3-kinase mediates ligation-stimulated CD28 phosphorylation, and (2) the PMA-stimulated down-regulation of the coupling of CD28 to PI 3-kinase is not due to PMA-stimulated phosphorylation of CD28.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337876      PMCID: PMC1218662          DOI: 10.1042/bj3260249

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  63 in total

1.  Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.

Authors:  C P Larsen; E T Elwood; D Z Alexander; S C Ritchie; R Hendrix; C Tucker-Burden; H R Cho; A Aruffo; D Hollenbaugh; P S Linsley; K J Winn; T C Pearson
Journal:  Nature       Date:  1996-05-30       Impact factor: 49.962

2.  A role for RANTES in T lymphocyte proliferation.

Authors:  L Turner; S G Ward; D Sansom; J Westwick
Journal:  Biochem Soc Trans       Date:  1996-02       Impact factor: 5.407

3.  Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association.

Authors:  F Pagès; M Ragueneau; S Klasen; M Battifora; D Couez; R Sweet; A Truneh; S G Ward; D Olive
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

4.  Phosphoinositide 3-kinase gamma and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or beta-phorbol myristate acetate and roles in promoting the ligand-binding function of alphaIIbbeta3 integrin.

Authors:  J Zhang; J Zhang; S J Shattil; M C Cunningham; S E Rittenhouse
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

5.  Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells.

Authors:  M Izquierdo; J Downward; J D Graves; D A Cantrell
Journal:  Mol Cell Biol       Date:  1992-07       Impact factor: 4.272

6.  Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation.

Authors:  P Rodriguez-Viciana; P H Warne; B Vanhaesebroeck; M D Waterfield; J Downward
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

7.  Identification of a putative target for Rho as the serine-threonine kinase protein kinase N.

Authors:  M Amano; H Mukai; Y Ono; K Chihara; T Matsui; Y Hamajima; K Okawa; A Iwamatsu; K Kaibuchi
Journal:  Science       Date:  1996-02-02       Impact factor: 47.728

8.  CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway.

Authors:  Y Lu; A Granelli-Piperno; J M Bjorndahl; C A Phillips; J M Trevillyan
Journal:  J Immunol       Date:  1992-07-01       Impact factor: 5.422

9.  Functional LCK Is required for optimal CD28-mediated activation of the TEC family tyrosine kinase EMT/ITK.

Authors:  S Gibson; A August; D Branch; B Dupont; G M Mills
Journal:  J Biol Chem       Date:  1996-03-22       Impact factor: 5.157

10.  CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C.

Authors:  J M Teng; X R Liu; G B Mills; B Dupont
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

View more
  2 in total

Review 1.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

Review 2.  CD28/CTLA-4 and CD80/CD86 families: signaling and function.

Authors:  J M Slavik; J E Hutchcroft; B E Bierer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.